Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 300, Issue 1-2, 2011, Pages 23-27

  Nefussy, Beatrice ^a   Hirsch, Jonathan ^b   Cudkowicz, Merit E ^c   Drory, Vivian E ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amyotrophic lateral sclerosis; Gender; Medications; Motor neuron disease; Statins

Indexed keywords

CELECOXIB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TOPIRAMATE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; DYSLIPIDEMIAS; FEMALE; FRUCTOSE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PYRAZOLES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; SULFONAMIDES;

EID: 78650509732     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.10.011     Document Type: Article

References (25)

1. I.R. Edwards, K. Star, and A. Kiuru Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase Drug Saf 30 2007 515 525 (Pubitemid 46873076)
2. E. Colman, A. Szarfman, J. Wyeth, A. Mosholder, D. Jillapalli, and J. Levine An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system Pharmacoepidemiol Drug Saf 17 2008 1068 1076
3. L. Zinman, R. Sadeghi, M. Gawel, D. Patton, and A. Kiss Are statin medications safe in patients with ALS? Amyotroph Lateral Scler 9 2008 223 228
4. M. Qureshi, A. Shui, A.B. Dibernardo, R.H. Brown Jr., D.A. Schoenfeld, and M.E. Cudkowicz Medication and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis Amyotroph Lateral Scler 9 2008 369 374
5. H.T. Sorensen, and T.L. Lash Statins and amyotrophic lateral sclerosis - the level of evidence for an association J Intern Med 266 2009 520 526
6. I. Dupuis, P. Corcia, A. Fargani, J.L. Gonzalez De Aguilar, D. Bonnefont-Roussel, and R. Bittar Dyslipidemia is a protective factor in amyotrophic lateral sclerosis Neurology 70 2008 1004 1009 (Pubitemid 351451324)
7. A. Chio, A. Calvo, A. Ilardi, E. Cavallo, C. Mogila, and R. Mutani Lower serum lipid levels are related to respiratory impairment in patients with ALS Neurology 73 2009 1681 1685
8. V.E. Drory, T. Bronipolski, I. Artamonov, and B. Nefussy Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis J Neurol Sci 273 2008 81 83
9. M. Cudkowicz, J. Shefner, D. Schoenfeld, R.H. Brown, H. Johnson, and M. Qureshi A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis Neurology 61 2003 456 464 (Pubitemid 37025360)
10. M. Cudkowicz, J. Shefner, D. Schoenfeld, H. Zhang, K. Anderson, and J. Rothstein Trial of celecoxib in amyotrophic lateral sclerosis Ann Neurol 60 2006 22 31 (Pubitemid 44174343)
11. C.R. Harper, and T.A. Jacobson The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis Curr Opin Lipidol 18 2007 401 408
12. S.C. Ahn Neuromuscular complications of statins Phys Med Rehabil Clin N Am 19 2008 47 59
13. A.M. Chancellor, J.M. Slattery, H. Frazer, R.J. Swingler, S.M. Holloway, and C.P. Wallow The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register J Neurol 240 1993 339 346 (Pubitemid 23230381)
14. M.A. del Aguila, W.T. Longstreth Jr., V. McGuire, T.D. Koepsell, and G. van Belle Prognosis in amyotrophic lateral sclerosis. A population-based study Neurology 60 2003 813 819 (Pubitemid 36297366)
15. J.M. Lopez-Vega, J. Calleja, O. Combarros, J.M. Polo, and J. Berciano Motor neuron disease in Cantabria Acta Neurol Scand 77 1988 1 5 (Pubitemid 18034185)
16. J. Marti-Fabregas, J. Fredas, and I. Illa Prognostic factors in amyotrophic lateral sclerosis Neurologia 11 1996 174 181 (Pubitemid 26244649)
17. A. Chio, G. Logroscino, O. Hardiman, R. Swinger, D. Mitchell, and E. Beghi Prognostic factors in ALS: a critical review Amyotroph Lateral Scler 10 2009 310 323
18. R.A. Popat, C.M. Tanner, S.K. van den Eeden, A.L. Bernstein, D.A. Bloch, and A. Leimpeter Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis Amyotroph Lateral Scler 8 2007 157 163 (Pubitemid 46887913)
19. D. Voora, S.H. Shah, I. Spasojevic, S. Ali, C.R. Reed, and B.A. Salisbury The SLCO1B1*5 genetic variant is associated with statin-induced side effects J Am Coll Cardiol 54 2009 1609 1619
20. T.R. Joy, and R.A. Hegele Narrative review: statin-related myopathy Ann Intern Med 150 2009 858 868
21. Collaborative Group SEARCH, E. Link, S. Parish, J. Armitage, L. Bowman, S. Heath, and F. Matsuda SLCO1B1 variants and statin-induced myopathy - a genome wide study N Engl J Med 359 2008 789 799
22. B.A. Golomb, E.K. Kwon, S. Koperski, and M.A. Evans Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study Drug Saf 32 2009 649 661
23. T. Eisenberg, and M.T. Wells Statins and adverse cardiovascular events in moderate-risk females: a statistical and legal analysis with implications for FDA preemption claims J Empirical Leg Stud 5 2008 507 550
24. M. Petretta, P. Costanzo, P. Perrone-Filardi, and M. Chiariello Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis Int J Cardiol 1 2010 25 31
25. S. Mora, R.J. Glynn, J. Hsia, J.G. MacFayden, J. Genest, and P.M. Ridker Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials Circulation 121 2010 1069 1077